A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children
aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and
about 320 patients will participate.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.